Drug
Brimonidine Tartrate, Timolol Maleate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Intraocular Pressure Increased | 293 | 74.2 | 77.6 | signal |
| 2 | Ocular Hyperaemia | 541 | 37.2 | 40.5 | signal |
| 3 | Eye Irritation | 524 | 30.2 | 32.7 | signal |
| 4 | Glaucoma | 164 | 27.3 | 28.0 | signal |
| 5 | Eye Pain | 470 | 27.3 | 29.3 | signal |
| 6 | Eye Discharge | 85 | 26.7 | 27.0 | signal |
| 7 | Eye Pruritus | 254 | 24.7 | 25.6 | signal |
| 8 | Ocular Discomfort | 65 | 19.1 | 19.3 | signal |
| 9 | Lacrimation Increased | 176 | 18.8 | 19.3 | signal |
| 10 | Product Packaging Quantity Issue | 58 | 17.0 | 17.1 | signal |
| 11 | Eye Inflammation | 49 | 16.6 | 16.7 | signal |
| 12 | Blindness Unilateral | 68 | 15.4 | 15.6 | signal |
| 13 | Eye Infection | 51 | 14.5 | 14.6 | signal |
| 14 | Eyelid Oedema | 51 | 13.9 | 14.0 | signal |
| 15 | Eye Swelling | 153 | 13.2 | 13.5 | signal |
| 16 | Photophobia | 74 | 12.6 | 12.8 | signal |
| 17 | Uveitis | 45 | 10.6 | 10.7 | signal |
| 18 | Visual Acuity Reduced | 109 | 10.4 | 10.5 | signal |
| 19 | Dry Eye | 138 | 9.1 | 9.3 | signal |
| 20 | Cataract | 160 | 8.6 | 8.8 | signal |
| 21 | Vitreous Floaters | 25 | 8.2 | 8.2 | signal |
| 22 | Vision Blurred | 337 | 7.9 | 8.2 | signal |
| 23 | Conjunctivitis | 45 | 7.8 | 7.8 | signal |
| 24 | Eye Disorder | 77 | 7.5 | 7.6 | signal |
| 25 | Retinal Detachment | 21 | 7.3 | 7.3 | signal |
| 26 | Eye Haemorrhage | 27 | 6.4 | 6.5 | signal |
| 27 | Eyelid Ptosis | 19 | 5.9 | 6.0 | signal |
| 28 | Blindness | 76 | 5.9 | 6.0 | signal |
| 29 | Product Use Complaint | 28 | 5.8 | 5.8 | signal |
| 30 | Macular Degeneration | 21 | 5.6 | 5.6 | signal |
| 31 | Visual Impairment | 211 | 5.5 | 5.6 | signal |
| 32 | Poor Quality Product Administered | 17 | 5.3 | 5.3 | signal |
| 33 | Accidental Exposure To Product | 157 | 5.0 | 5.1 | signal |
| 34 | Dry Mouth | 116 | 4.6 | 4.6 | signal |
| 35 | Product Packaging Issue | 13 | 4.5 | 4.5 | signal |
| 36 | Heart Rate Decreased | 49 | 4.4 | 4.4 | signal |
| 37 | Product Storage Error | 117 | 4.3 | 4.4 | signal |
| 38 | Product Dose Omission | 85 | 4.1 | 4.1 | signal |
| 39 | Prostatic Specific Antigen Increased | 17 | 3.9 | 3.9 | signal |
| 40 | Body Height Decreased | 13 | 3.8 | 3.8 | signal |
| 41 | Product Administration Error | 23 | 3.7 | 3.7 | signal |
| 42 | Inappropriate Schedule Of Drug Administration | 81 | 3.6 | 3.6 | signal |
| 43 | Mydriasis | 14 | 3.5 | 3.5 | signal |
| 44 | Sluggishness | 11 | 3.4 | 3.5 | signal |
| 45 | Impaired Driving Ability | 12 | 3.4 | 3.4 | signal |
| 46 | Bradycardia | 56 | 3.4 | 3.4 | signal |
| 47 | Madarosis | 12 | 3.3 | 3.3 | signal |
| 48 | Device Use Issue | 17 | 3.1 | 3.1 | signal |
| 49 | Small Intestinal Obstruction | 12 | 3.1 | 3.1 | signal |
| 50 | End Stage Renal Disease | 18 | 3.1 | 3.1 | signal |
| 51 | Scab | 11 | 3.1 | 3.1 | signal |
| 52 | Heart Rate Irregular | 22 | 3.1 | 3.1 | signal |
| 53 | Blood Pressure Decreased | 62 | 3.0 | 3.0 | signal |
| 54 | Sinus Bradycardia | 9 | 3.0 | 3.0 | signal |
| 55 | Vitamin D Deficiency | 9 | 2.9 | 2.9 | signal |
| 56 | Blood Thyroid Stimulating Hormone Increased | 8 | 2.8 | 2.8 | signal |
| 57 | Expired Product Administered | 28 | 2.7 | 2.7 | signal |
| 58 | Hypersensitivity | 156 | 2.7 | 2.7 | signal |
| 59 | Blood Pressure Fluctuation | 20 | 2.6 | 2.6 | signal |
| 60 | Chronic Kidney Disease | 62 | 2.6 | 2.6 | signal |
| 61 | Diplopia | 21 | 2.6 | 2.6 | signal |
| 62 | Product Complaint | 20 | 2.5 | 2.6 | signal |
| 63 | Peripheral Coldness | 11 | 2.5 | 2.5 | signal |
| 64 | Dermatitis Contact | 9 | 2.5 | 2.5 | signal |
| 65 | Dry Throat | 8 | 2.5 | 2.5 | signal |
| 66 | Rhinorrhoea | 50 | 2.5 | 2.5 | signal |
| 67 | Sneezing | 17 | 2.4 | 2.4 | signal |
| 68 | Sinus Disorder | 15 | 2.4 | 2.4 | signal |
| 69 | Wound | 21 | 2.4 | 2.4 | signal |
| 70 | Full Blood Count Decreased | 15 | 2.4 | 2.4 | signal |
| 71 | Sputum Discoloured | 7 | 2.4 | 2.4 | signal |
| 72 | Head Discomfort | 13 | 2.3 | 2.4 | signal |
| 73 | Dizziness Postural | 7 | 2.3 | 2.3 | signal |
| 74 | Osteopenia | 11 | 2.3 | 2.3 | signal |
| 75 | Hip Fracture | 23 | 2.3 | 2.3 | signal |
| 76 | Balance Disorder | 62 | 2.3 | 2.3 | signal |
| 77 | Hypotonia | 7 | 2.2 | 2.2 | no signal |
| 78 | Pallor | 19 | 2.2 | 2.2 | signal |
| 79 | Respiratory Tract Congestion | 11 | 2.2 | 2.2 | signal |
| 80 | Initial Insomnia | 7 | 2.2 | 2.2 | no signal |
| 81 | Muscular Weakness | 78 | 2.2 | 2.2 | signal |
| 82 | Weight Fluctuation | 7 | 2.1 | 2.1 | no signal |
| 83 | Tooth Disorder | 15 | 2.1 | 2.1 | signal |
| 84 | Full Blood Count Abnormal | 7 | 2.1 | 2.1 | no signal |
| 85 | Drug Administered At Inappropriate Site | 7 | 2.1 | 2.1 | no signal |
| 86 | Hypercalcaemia | 8 | 2.1 | 2.1 | no signal |
| 87 | Secretion Discharge | 8 | 2.1 | 2.1 | no signal |
| 88 | Lymphopenia | 9 | 2.0 | 2.0 | no signal |
| 89 | Seasonal Allergy | 9 | 2.0 | 2.0 | no signal |
| 90 | Skin Fissures | 12 | 2.0 | 2.0 | signal |
| 91 | Hypersomnia | 18 | 2.0 | 2.0 | no signal |
| 92 | Red Blood Cell Count Decreased | 18 | 2.0 | 2.0 | no signal |
| 93 | Pollakiuria | 26 | 2.0 | 2.0 | no signal |
| 94 | Micturition Urgency | 7 | 2.0 | 2.0 | no signal |
| 95 | Hallucination | 46 | 2.0 | 2.0 | no signal |
| 96 | Somnolence | 122 | 1.9 | 1.9 | no signal |
| 97 | Tooth Infection | 8 | 1.9 | 1.9 | no signal |
| 98 | Incorrect Dose Administered | 136 | 1.9 | 1.9 | no signal |
| 99 | Body Temperature Decreased | 6 | 1.9 | 1.9 | no signal |
| 100 | Fall | 197 | 1.9 | 1.9 | no signal |
| 101 | Ear Discomfort | 6 | 1.9 | 1.9 | no signal |
| 102 | Feeling Cold | 16 | 1.8 | 1.8 | no signal |
| 103 | Carpal Tunnel Syndrome | 8 | 1.8 | 1.8 | no signal |
| 104 | Frequent Bowel Movements | 15 | 1.8 | 1.8 | no signal |
| 105 | Atrial Fibrillation | 54 | 1.8 | 1.8 | no signal |
| 106 | Product Physical Issue | 11 | 1.8 | 1.8 | no signal |
| 107 | Hypophagia | 14 | 1.8 | 1.8 | no signal |
| 108 | Product Dispensing Error | 12 | 1.8 | 1.8 | no signal |
| 109 | Hypotension | 109 | 1.7 | 1.7 | no signal |
| 110 | Syncope | 54 | 1.7 | 1.7 | no signal |
| 111 | Dizziness | 268 | 1.7 | 1.7 | no signal |
| 112 | Dermatitis | 11 | 1.7 | 1.7 | no signal |
| 113 | Drug Dose Omission | 89 | 1.7 | 1.7 | no signal |
| 114 | Hallucination, Visual | 11 | 1.7 | 1.7 | no signal |
| 115 | Musculoskeletal Disorder | 10 | 1.7 | 1.7 | no signal |
| 116 | Tinnitus | 24 | 1.7 | 1.7 | no signal |
| 117 | Burning Sensation | 36 | 1.6 | 1.6 | no signal |
| 118 | Product Quality Issue | 69 | 1.6 | 1.6 | no signal |
| 119 | Hospice Care | 5 | 1.6 | 1.6 | no signal |
| 120 | Head Injury | 16 | 1.6 | 1.6 | no signal |
| 121 | Dementia | 14 | 1.6 | 1.6 | no signal |
| 122 | Bladder Disorder | 5 | 1.6 | 1.6 | no signal |
| 123 | Wrist Fracture | 6 | 1.6 | 1.6 | no signal |
| 124 | Mass | 7 | 1.6 | 1.6 | no signal |
| 125 | Toothache | 9 | 1.6 | 1.6 | no signal |
| 126 | Ovarian Cyst | 5 | 1.6 | 1.6 | no signal |
| 127 | Dysphonia | 29 | 1.6 | 1.6 | no signal |
| 128 | Sensory Disturbance | 8 | 1.6 | 1.6 | no signal |
| 129 | Nocturia | 6 | 1.6 | 1.6 | no signal |
| 130 | Rash Generalised | 13 | 1.6 | 1.6 | no signal |
| 131 | Fatigue | 383 | 1.6 | 1.6 | no signal |
| 132 | Product Dose Omission Issue | 140 | 1.6 | 1.6 | no signal |
| 133 | Drug Effect Incomplete | 18 | 1.6 | 1.6 | no signal |
| 134 | Sinusitis | 50 | 1.5 | 1.6 | no signal |
| 135 | Product Odour Abnormal | 5 | 1.5 | 1.5 | no signal |
| 136 | Skin Exfoliation | 40 | 1.5 | 1.5 | no signal |
| 137 | Skin Discolouration | 22 | 1.5 | 1.5 | no signal |
| 138 | Transient Ischaemic Attack | 16 | 1.5 | 1.5 | no signal |
| 139 | Mood Swings | 15 | 1.5 | 1.5 | no signal |
| 140 | Erythema | 95 | 1.5 | 1.5 | no signal |
| 141 | Faeces Discoloured | 10 | 1.5 | 1.5 | no signal |
| 142 | Vertigo | 28 | 1.5 | 1.5 | no signal |
| 143 | Pruritus Generalised | 10 | 1.4 | 1.4 | no signal |
| 144 | Thyroid Disorder | 7 | 1.4 | 1.4 | no signal |
| 145 | Drug Hypersensitivity | 88 | 1.4 | 1.4 | no signal |
| 146 | Diabetes Mellitus Inadequate Control | 8 | 1.4 | 1.4 | no signal |
| 147 | Ankle Fracture | 7 | 1.4 | 1.4 | no signal |
| 148 | Red Blood Cell Sedimentation Rate Increased | 5 | 1.4 | 1.4 | no signal |
| 149 | Treatment Failure | 37 | 1.4 | 1.4 | no signal |
| 150 | Upper Limb Fracture | 9 | 1.4 | 1.4 | no signal |
| 151 | Arthropathy | 25 | 1.4 | 1.4 | no signal |
| 152 | Quality Of Life Decreased | 6 | 1.4 | 1.4 | no signal |
| 153 | Therapeutic Response Unexpected | 20 | 1.4 | 1.4 | no signal |
| 154 | Accidental Overdose | 16 | 1.4 | 1.4 | no signal |
| 155 | Diverticulitis | 12 | 1.4 | 1.4 | no signal |
| 156 | Increased Tendency To Bruise | 4 | 1.4 | 1.4 | no signal |
| 157 | Amnesia | 28 | 1.4 | 1.4 | no signal |
| 158 | Coronary Artery Disease | 13 | 1.4 | 1.4 | no signal |
| 159 | Intentional Product Misuse | 37 | 1.4 | 1.4 | no signal |
| 160 | Leukaemia | 4 | 1.3 | 1.3 | no signal |
| 161 | Spinal Disorder | 4 | 1.3 | 1.3 | no signal |
| 162 | Eating Disorder | 9 | 1.3 | 1.3 | no signal |
| 163 | Covid-19 Pneumonia | 5 | 1.3 | 1.3 | no signal |
| 164 | Bronchospasm | 6 | 1.3 | 1.3 | no signal |
| 165 | Hypoacusis | 18 | 1.3 | 1.3 | no signal |
| 166 | Therapy Change | 4 | 1.3 | 1.3 | no signal |
| 167 | Therapeutic Response Decreased | 25 | 1.3 | 1.3 | no signal |
| 168 | Skin Irritation | 19 | 1.3 | 1.3 | no signal |
| 169 | Flatulence | 23 | 1.3 | 1.3 | no signal |
| 170 | Movement Disorder | 13 | 1.3 | 1.3 | no signal |
| 171 | Intentional Dose Omission | 11 | 1.3 | 1.3 | no signal |
| 172 | Nervousness | 21 | 1.3 | 1.3 | no signal |
| 173 | Therapy Partial Responder | 6 | 1.3 | 1.3 | no signal |
| 174 | Temperature Intolerance | 4 | 1.2 | 1.2 | no signal |
| 175 | Inappropriate Schedule Of Product Administration | 69 | 1.2 | 1.2 | no signal |
| 176 | Dry Skin | 51 | 1.2 | 1.2 | no signal |
| 177 | Poor Venous Access | 4 | 1.2 | 1.2 | no signal |
| 178 | Folliculitis | 4 | 1.2 | 1.2 | no signal |
| 179 | Scratch | 4 | 1.2 | 1.2 | no signal |
| 180 | Drug Administration Error | 12 | 1.2 | 1.2 | no signal |
| 181 | Nodule | 5 | 1.2 | 1.2 | no signal |
| 182 | Angina Pectoris | 11 | 1.2 | 1.2 | no signal |
| 183 | Middle Insomnia | 7 | 1.2 | 1.2 | no signal |
| 184 | Extra Dose Administered | 15 | 1.2 | 1.2 | no signal |
| 185 | Incorrect Product Storage | 5 | 1.2 | 1.2 | no signal |
| 186 | Product Dose Omission In Error | 10 | 1.2 | 1.2 | no signal |
| 187 | Skin Cancer | 8 | 1.2 | 1.2 | no signal |
| 188 | Renal Injury | 11 | 1.2 | 1.2 | no signal |
| 189 | Pulmonary Thrombosis | 4 | 1.2 | 1.2 | no signal |
| 190 | Hernia | 7 | 1.2 | 1.2 | no signal |
| 191 | Dysgeusia | 27 | 1.1 | 1.2 | no signal |
| 192 | No Adverse Event | 64 | 1.1 | 1.1 | no signal |
| 193 | Device Occlusion | 5 | 1.1 | 1.1 | no signal |
| 194 | Oral Discomfort | 5 | 1.1 | 1.1 | no signal |
| 195 | Throat Irritation | 16 | 1.1 | 1.1 | no signal |
| 196 | Upper Gastrointestinal Haemorrhage | 6 | 1.1 | 1.1 | no signal |
| 197 | Fistula | 4 | 1.1 | 1.1 | no signal |
| 198 | Disability | 7 | 1.1 | 1.1 | no signal |
| 199 | Wrong Technique In Product Usage Process | 71 | 1.1 | 1.1 | no signal |
| 200 | Spinal Fracture | 7 | 1.1 | 1.1 | no signal |
| 201 | Activities Of Daily Living Impaired | 7 | 1.1 | 1.1 | no signal |
| 202 | Subdural Haematoma | 5 | 1.1 | 1.1 | no signal |
| 203 | Therapy Interrupted | 24 | 1.1 | 1.1 | no signal |
| 204 | Impaired Quality Of Life | 5 | 1.1 | 1.1 | no signal |
| 205 | Hot Flush | 26 | 1.1 | 1.1 | no signal |
| 206 | Apathy | 5 | 1.1 | 1.1 | no signal |
| 207 | Spinal Pain | 4 | 1.1 | 1.1 | no signal |
| 208 | Haemorrhage Intracranial | 5 | 1.1 | 1.1 | no signal |
| 209 | Spinal Operation | 4 | 1.1 | 1.1 | no signal |
| 210 | Influenza Like Illness | 27 | 1.0 | 1.0 | no signal |
| 211 | Nerve Compression | 3 | 1.0 | 1.0 | no signal |
| 212 | Blood Glucose Abnormal | 6 | 1.0 | 1.0 | no signal |
| 213 | Cardiac Failure Congestive | 26 | 1.0 | 1.0 | no signal |
| 214 | Hair Colour Changes | 4 | 1.0 | 1.0 | no signal |
| 215 | Glycosylated Haemoglobin Increased | 8 | 1.0 | 1.0 | no signal |
| 216 | Fracture | 6 | 1.0 | 1.0 | no signal |
| 217 | Eructation | 6 | 1.0 | 1.0 | no signal |
| 218 | Drug Reaction With Eosinophilia And Systemic Symptoms | 8 | 1.0 | 1.0 | no signal |
| 219 | Circumstance Or Information Capable Of Leading To Medication Error | 10 | 0.9 | 0.9 | no signal |
| 220 | Product Taste Abnormal | 4 | 0.9 | 0.9 | no signal |
| 221 | Gynaecomastia | 9 | 0.9 | 0.9 | no signal |
| 222 | Metastases To Liver | 5 | 0.9 | 0.9 | no signal |
| 223 | Incorrect Drug Administration Duration | 8 | 0.9 | 0.9 | no signal |
| 224 | Pulmonary Arterial Hypertension | 4 | 0.9 | 0.9 | no signal |
| 225 | Wrong Technique In Drug Usage Process | 10 | 0.9 | 0.9 | no signal |
| 226 | Fluid Overload | 4 | 0.9 | 0.9 | no signal |
| 227 | Blood Glucose Increased | 49 | 0.8 | 0.8 | no signal |
| 228 | Drug Prescribing Error | 5 | 0.8 | 0.8 | no signal |
| 229 | Palmar-plantar Erythrodysaesthesia Syndrome | 6 | 0.8 | 0.8 | no signal |
| 230 | Neoplasm Progression | 9 | 0.8 | 0.8 | no signal |
| 231 | Abnormal Behaviour | 10 | 0.8 | 0.8 | no signal |
| 232 | Osteonecrosis Of Jaw | 6 | 0.8 | 0.8 | no signal |
| 233 | Abasia | 6 | 0.8 | 0.8 | no signal |
| 234 | Plasma Cell Myeloma | 9 | 0.7 | 0.7 | no signal |
| 235 | Ankylosing Spondylitis | 3 | 0.7 | 0.7 | no signal |
| 236 | Myocardial Infarction | 40 | 0.7 | 0.7 | no signal |
| 237 | Complication Associated With Device | 3 | 0.7 | 0.7 | no signal |
| 238 | Malignant Neoplasm Progression | 23 | 0.7 | 0.7 | no signal |
| 239 | Product Availability Issue | 5 | 0.7 | 0.7 | no signal |
| 240 | Hair Texture Abnormal | 3 | 0.7 | 0.7 | no signal |
| 241 | Exposure Via Skin Contact | 5 | 0.7 | 0.7 | no signal |
| 242 | Product Administered At Inappropriate Site | 4 | 0.7 | 0.7 | no signal |
| 243 | Drug Dispensing Error | 3 | 0.6 | 0.6 | no signal |
| 244 | Psoriasis | 25 | 0.6 | 0.6 | no signal |
| 245 | Multiple Fractures | 3 | 0.6 | 0.6 | no signal |
| 246 | Injection Site Reaction | 12 | 0.6 | 0.6 | no signal |
| 247 | Device Issue | 15 | 0.5 | 0.5 | no signal |
| 248 | Injection Site Pruritus | 11 | 0.5 | 0.5 | no signal |
| 249 | Injection Site Bruising | 13 | 0.5 | 0.5 | no signal |
| 250 | Drug Effect Decreased | 9 | 0.5 | 0.5 | no signal |
| 251 | Device Malfunction | 11 | 0.5 | 0.5 | no signal |
| 252 | Therapeutic Response Shortened | 5 | 0.5 | 0.5 | no signal |
| 253 | Application Site Erythema | 4 | 0.5 | 0.5 | no signal |
| 254 | Multiple Sclerosis | 7 | 0.5 | 0.5 | no signal |
| 255 | Skin Burning Sensation | 10 | 0.4 | 0.4 | no signal |
| 256 | Injection Site Haemorrhage | 11 | 0.4 | 0.4 | no signal |
| 257 | Device Dislocation | 6 | 0.4 | 0.4 | no signal |
| 258 | Injection Site Mass | 5 | 0.4 | 0.4 | no signal |
| 259 | Application Site Pruritus | 3 | 0.4 | 0.4 | no signal |
| 260 | Injection Site Pain | 40 | 0.4 | 0.4 | no signal |
| 261 | Multiple Sclerosis Relapse | 9 | 0.4 | 0.4 | no signal |
| 262 | Dermatitis Atopic | 6 | 0.4 | 0.4 | no signal |
| 263 | Device Delivery System Issue | 3 | 0.4 | 0.4 | no signal |
| 264 | Injection Site Erythema | 14 | 0.4 | 0.4 | no signal |
| 265 | Incorrect Route Of Drug Administration | 4 | 0.4 | 0.4 | no signal |
| 266 | Wrong Technique In Device Usage Process | 5 | 0.3 | 0.3 | no signal |
| 267 | Breast Cancer | 10 | 0.3 | 0.3 | no signal |
| 268 | Device Breakage | 4 | 0.3 | 0.3 | no signal |
| 269 | Prostate Cancer | 8 | 0.3 | 0.3 | no signal |
| 270 | Device Leakage | 4 | 0.3 | 0.3 | no signal |
| 271 | Device Difficult To Use | 6 | 0.3 | 0.3 | no signal |
| 272 | Renal Cancer | 3 | 0.2 | 0.2 | no signal |